Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications

被引:93
|
作者
Zhong, Qian
Xiao, Xina
Qiu, Yijie
Xu, Zhiqiang
Chen, Chunyu
Chong, Baochen
Zhao, Xinjun
Hai, Shan
Li, Shuangqing
An, Zhenmei
Dai, Lunzhi
机构
[1] Sichuan Univ, Dept Endocrinol & Metab, Gen Practice Ward, Gen Practice Med Ctr,Int Med Ctr Ward, Chengdu, Peoples R China
[2] Sichuan Univ, West China Hosp, Natl Clin Res Ctr Geriatr, State Key Lab Biotherapy, Chengdu, Peoples R China
来源
MEDCOMM | 2023年 / 4卷 / 03期
基金
国家重点研发计划; 中国国家自然科学基金;
关键词
aging; cancers; metabolic diseases; neurodegenerative diseases; protein posttranslational modifications; targeted therapy; NF-KAPPA-B; UBIQUITIN-PROTEASOME SYSTEM; TYROSINE KINASE INHIBITORS; CELL LUNG-CANCER; HISTONE METHYLTRANSFERASE G9A; AMYLOID PRECURSOR PROTEIN; CYSTEINE-SULFINIC ACID; NITRIC-OXIDE SYNTHASE; CHAIN FATTY-ACIDS; INTEGRATED PROTEOGENOMIC CHARACTERIZATION;
D O I
10.1002/mco2.261
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Protein posttranslational modifications (PTMs) refer to the breaking or generation of covalent bonds on the backbones or amino acid side chains of proteins and expand the diversity of proteins, which provides the basis for the emergence of organismal complexity. To date, more than 650 types of protein modifications, such as the most well-known phosphorylation, ubiquitination, glycosylation, methylation, SUMOylation, short-chain and long-chain acylation modifications, redox modifications, and irreversible modifications, have been described, and the inventory is still increasing. By changing the protein conformation, localization, activity, stability, charges, and interactions with other biomolecules, PTMs ultimately alter the phenotypes and biological processes of cells. The homeostasis of protein modifications is important to human health. Abnormal PTMs may cause changes in protein properties and loss of protein functions, which are closely related to the occurrence and development of various diseases. In this review, we systematically introduce the characteristics, regulatory mechanisms, and functions of various PTMs in health and diseases. In addition, the therapeutic prospects in various diseases by targeting PTMs and associated regulatory enzymes are also summarized. This work will deepen the understanding of protein modifications in health and diseases and promote the discovery of diagnostic and prognostic markers and drug targets for diseases.
引用
收藏
页数:112
相关论文
共 36 条
  • [1] Posttranslational modifications of histone deacetylases: Implications for cardiovascular diseases
    Eom, Gwang Hyeon
    Kook, Hyun
    PHARMACOLOGY & THERAPEUTICS, 2014, 143 (02) : 168 - 180
  • [2] Posttranslational Modifications of a-Synuclein, Their Therapeutic Potential, and Crosstalk in Health and Neurodegenerative Diseases
    Hassanzadeh, Kambiz
    Liu, Jun
    Maddila, Santhosh
    Mouradian, M. Maral
    PHARMACOLOGICAL REVIEWS, 2024, 76 (06) : 1254 - 1290
  • [3] A survey of protein interactions and posttranslational modifications that influence the polyglutamine diseases
    Johnson, Sean L.
    Tsou, Wei-Ling
    Prifti, Matthew V.
    Harris, Autumn L.
    Todi, Sokol V.
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2022, 15
  • [4] Emerging regulatory mechanisms and functions of biomolecular condensates: implications for therapeutic targets
    Jeon, Soyoung
    Jeon, Yeram
    Lim, Ji-Youn
    Kim, Yujeong
    Cha, Boksik
    Kim, Wantae
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2025, 10 (01)
  • [5] Non-enzymatic posttranslational protein modifications in protein aggregation and neurodegenerative diseases
    Baldensperger, Tim
    Preissler, Miriam
    Becker, Christian F. W.
    RSC CHEMICAL BIOLOGY, 2025, 6 (02): : 129 - 149
  • [6] Protein posttranslational modifications in metabolic diseases: basic concepts and targeted therapies
    Yang, Yunuo
    Wu, Jiaxuan
    Zhou, Wenjun
    Ji, Guang
    Dang, Yanqi
    MEDCOMM, 2024, 5 (10):
  • [7] Neurodegenerative diseases: Epigenetic regulatory mechanisms and therapeutic potential
    Men, Jianbing
    Wang, Xinyue
    Zhou, Yunnuo
    Huang, Yumeng
    Zheng, Yue
    Wang, Yingze
    Yang, Shuang
    Chen, Nan
    Yan, Nan
    Duan, Xiaoxu
    CELLULAR SIGNALLING, 2025, 131
  • [8] Immunometabolism of Tregs: mechanisms, adaptability, and therapeutic implications in diseases
    Lu, Yuming
    Wang, Yifan
    Ruan, Tiantian
    Wang, Yihan
    Ju, Linling
    Zhou, Mengya
    Liu, Luyin
    Yao, Dengfu
    Yao, Min
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [9] The Crucial Role of the Blood-Brain Barrier in Neurodegenerative Diseases: Mechanisms of Disruption and Therapeutic Implications
    Kim, Sehwan
    Jung, Un Ju
    Kim, Sang Ryong
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (02)
  • [10] Ribosomal Proteins and Human Diseases: Pathogenesis, Molecular Mechanisms, and Therapeutic Implications
    Wang, Wei
    Nag, Subhasree
    Zhang, Xu
    Wang, Ming-Hai
    Wang, Hui
    Zhou, Jianwei
    Zhang, Ruiwen
    MEDICINAL RESEARCH REVIEWS, 2015, 35 (02) : 225 - 285